Salute e Benessere
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
"At ZEISS, we continue to enhance the ZEISS Retina Workflow with new capabilities, to help empower clinicians who are redefining vitreoretinal surgery and advance retinal care," says Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology. "We're excited to continue leading in this area and meeting the evolving needs of surgeons from around the world with one of the few end-to-end retina ecosystems in the industry."
"By combining the strengths of ZEISS and DORC, we're reducing complexity to help enable retina specialists around the world to diagnose earlier, treat with greater precision, and monitor more effectively - through an expanding connected workflow," says Pierre Billardon , Head of Business Sectors Surgery Posterior Segment at ZEISS Medical Technology and CEO of DORC International.
ZEISS will highlight recent enhancements to its diagnostic portfolio within the ZEISS Retina Workflow, including the integration of digital tools aimed at supporting clinicians in detecting pathology more efficiently and precisely. At EURETINA, ZEISS will showcase several of these innovations, including:
Attendees can learn more about the latest diagnostic offerings within the ZEISS Retina Workflow at the ZEISS booth #2.B20:
With the ongoing integration of solutions from DORC, the ZEISS Retina Workflow solutions aim to help enable surgeons with increased predictability and efficiency in vitreoretinal surgery, offering a digitally connected portfolio from diagnostics through surgery and post-op care, supporting more precise planning and execution of surgical maneuvers.
ZEISS is introducing at EURETINA, a new high-speed cutter for the EVA NEXUS™ phacovitrectomy system that enables SMART IOP™ for posterior surgery to provide constant intraoperative stability. TDC VELOCE combines performance, control, stability and a new ergonomic design that offers improved aspiration flow for 25G/27G, a higher cut speed of up to 20k CPM , an ergonomic, contoured soft grip, and increased shaft stiffness for ease of reaching the periphery and shaving the vitreous base.
"With TDC VELOCE we were able to raise the limits of flow and rigidity. TDC VELOCE in combination with EVA NEXUS SMART IOP for posterior surgery sets new standards in IOP stability during vitreous shaving," shared TDC VELOCE co-developer Professor Mitrofanis Pavlidis, MD, PH.D., Augenzentrum Köln, Germany .
Attendees can learn more about the latest surgical offerings within the ZEISS Retina Workflow at the ZEISS booth #2.B20:
At EURETINA, ZEISS will also showcase for ZEISS ARTEVO 750 and ZEISS ARTEVO 850. The updated ZEISS CALLISTO eye software allows for visualization of retinal structures on the 3D screen of the ZEISS ARTEVO 850 with up to 30% higher magnification. Advanced camera settings, including automatic exposure control, provide customization of the visualization experience to the surgeon's individual preferences. In addition, the software update now also offers reference image matching for toric IOL implantations in either the eyepiece of the ZEISS ARTEVO 750 or the 3D monitor of the ZEISS ARTEVO 850 as well as optional 3D recording on the ZEISS ARTEVO 850.
ZEISS is showcasing additional innovations within the ZEISS Retina Workflow at EURETINA, including:
ZEISS will showcase its latest diagnostic and surgical offerings and new innovations at the European Society of Retina Specialists (EURETINA) conference from Sept. 4 – 7, 2025, at booth #2.B20.
For more information, visit www.zeiss.com/med.
Sebastian Frericks
Head of Group Finance & Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: investors.med@zeiss.com
Frank Smith
Head of Global Communications Ophthalmology
Carl Zeiss Meditec AG
Phone: +49 3641 220 331
Mail: press.med@zeiss.com
www.zeiss.com/newsroom
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September).
The Group's head office is located in Jena, Germany , and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA , Japan , Spain and France . The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China , strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
For further information visit: www.zeiss.com/med
Video - https://mma.prnewswire.com/media/2757848/CIRRUS_PathFinder_KV_VIdeo_1440x1800.mp4
Photo - https://mma.prnewswire.com/media/2757845/ZEISS_Research_Data_Platform.jpg
Photo - https://mma.prnewswire.com/media/2757846/TDC_VELOCE_from_DORC.jpg
Photo - https://mma.prnewswire.com/media/2757847/ARTEVO_850_with_CALLISTO_eye_Retina_OCT.jpg
Logo - https://mma.prnewswire.com/media/546786/ZEISS_v1_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/zeiss-showcases-comprehensive-workflow-for-full-spectrum-of-retina-care-at-euretina-302538637.html